BlackRock’s Anika Therapeutics ANIK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$23.1M Sell
1,594,893
-59,644
-4% -$692K ﹤0.01% 2986
2025
Q4
$15.9M Sell
1,654,537
-87,225
-5% -$835K ﹤0.01% 3211
2025
Q3
$16.4M Buy
1,741,762
+213,476
+14% +$2.04M ﹤0.01% 3205
2025
Q2
$16.2M Buy
1,528,286
+9,025
+0.6% +$114K ﹤0.01% 3151
2025
Q1
$22.8M Sell
1,519,261
-38,621
-2% -$642K ﹤0.01% 2851
2024
Q4
$25.6M Sell
1,557,882
-206,725
-12% -$4.08M ﹤0.01% 2888
2024
Q3
$43.6M Buy
1,764,607
+157,707
+10% +$4.09M ﹤0.01% 2551
2024
Q2
$40.7M Buy
1,606,900
+45,788
+3% +$1.19M ﹤0.01% 2547
2024
Q1
$39.7M Buy
1,561,112
+177,235
+13% +$4.29M ﹤0.01% 2581
2023
Q4
$31.4M Sell
1,383,877
-32,258
-2% -$667K ﹤0.01% 2753
2023
Q3
$26.4M Sell
1,416,135
-1,041,998
-42% -$21.6M ﹤0.01% 2783
2023
Q2
$63.9M Buy
2,458,133
+1,361
+0.1% +$36.4K ﹤0.01% 2336
2023
Q1
$70.6M Sell
2,456,772
-70,030
-3% -$2.08M ﹤0.01% 2230
2022
Q4
$74.8M Buy
2,526,802
+67,621
+3% +$1.92M ﹤0.01% 2208
2022
Q3
$58.5M Buy
2,459,181
+49,994
+2% +$1.15M ﹤0.01% 2322
2022
Q2
$53.8M Buy
2,409,187
+23,642
+1% +$527K ﹤0.01% 2434
2022
Q1
$59.9M Buy
2,385,545
+26,928
+1% +$821K ﹤0.01% 2477
2021
Q4
$84.5M Buy
2,358,617
+46,837
+2% +$1.87M ﹤0.01% 2323
2021
Q3
$98.4M Sell
2,311,780
-44,155
-2% -$1.82M ﹤0.01% 2230
2021
Q2
$102M Sell
2,355,935
-3,255
-0.1% -$139K ﹤0.01% 2235
2021
Q1
$96.2M Buy
2,359,190
+108,900
+5% +$4.13M ﹤0.01% 2214
2020
Q4
$102M Buy
2,250,290
+108,873
+5% +$4.13M ﹤0.01% 2068
2020
Q3
$75.8M Buy
2,141,417
+13,885
+0.7% +$502K ﹤0.01% 2059
2020
Q2
$80.3M Buy
2,127,532
+35,334
+2% +$1.16M ﹤0.01% 1980
2020
Q1
$60.5M Sell
2,092,198
-35,051
-2% -$1.42M ﹤0.01% 1945
2019
Q4
$110M Buy
2,127,249
+39,851
+2% +$2.31M ﹤0.01% 1901
2019
Q3
$115M Sell
2,087,398
-72,587
-3% -$3.73M ﹤0.01% 1819
2019
Q2
$87.7M Buy
2,159,985
+33,868
+2% +$1.23M ﹤0.01% 1994
2019
Q1
$64.3M Buy
2,126,117
+13,068
+0.6% +$448K ﹤0.01% 2139
2018
Q4
$71M Sell
2,113,049
-23,313
-1% -$841K ﹤0.01% 2028
2018
Q3
$90.1M Buy
2,136,362
+78,532
+4% +$3.1M ﹤0.01% 2036
2018
Q2
$65.9M Buy
2,057,830
+147,627
+8% +$6.08M ﹤0.01% 2203
2018
Q1
$95M Buy
1,910,203
+33,558
+2% +$1.9M ﹤0.01% 1882
2017
Q4
$101M Buy
1,876,645
+58,120
+3% +$3.22M ﹤0.01% 1874
2017
Q3
$105M Buy
1,818,525
+33,044
+2% +$1.73M 0.01% 1830
2017
Q2
$88.1M Sell
1,785,481
-2,044
-0.1% -$94.1K ﹤0.01% 1892
2017
Q1
$77.7M Buy
1,787,525
+1,785,701
+97,900% +$85.2M ﹤0.01% 1941
2016
Q4
$89K Sell
1,824
-169
-8% -$7.81K ﹤0.01% 2621
2016
Q3
$96K Sell
1,993
-39
-2% -$1.93K ﹤0.01% 2613
2016
Q2
$109K Buy
2,032
+1,011
+99% +$47.6K ﹤0.01% 2481
2016
Q1
$45K Buy
1,021
+186
+22% +$7.54K ﹤0.01% 2419
2015
Q4
$32K Sell
835
-356
-30% -$13.6K ﹤0.01% 2314
2015
Q3
$38K Buy
1,191
+900
+309% +$31.4K ﹤0.01% 2026
2015
Q2
$10K Sell
291
-40
-12% -$1.43K ﹤0.01% 2773
2015
Q1
$14K Hold
331
﹤0.01% 2527
2014
Q4
$13K Hold
331
﹤0.01% 2589
2014
Q3
$12K Hold
331
﹤0.01% 2596
2014
Q2
$15K Buy
331
+27
+9% +$1.2K ﹤0.01% 2532
2014
Q1
$12K Hold
304
﹤0.01% 2597
2013
Q4
$12K Sell
304
-50
-14% -$1.54K ﹤0.01% 2601
2013
Q3
$8K Hold
354
﹤0.01% 2765
2013
Q2
$6K Buy
+354
New +$5.11K ﹤0.01% 2940

Other funds holding ANIK